Title : Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages.

Pub. Date : 2022 Apr

PMID : 35137954






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages. Fumarates NLR family pyrin domain containing 3 Homo sapiens
2 Derivatives of the metabolites itaconate and fumarate, dimethyl itaconate (DMI), 4-octyl itaconate (4OI) and dimethyl fumarate (DMF), limit both expression and release of IL-1beta following NLRP3 inflammasome activation. Fumarates NLR family pyrin domain containing 3 Homo sapiens
3 DMI, 4OI, DMF and monomethyl fumarate (MMF), another fumarate derivative, also directly inhibited biochemical markers of NLRP3 activation in LPS-primed macrophages, mixed glia, OHSCs and human macrophages in response to nigericin and imiquimod, including ASC speck formation, caspase-1 activation, gasdermin D cleavage and IL-1beta release. Fumarates NLR family pyrin domain containing 3 Homo sapiens
4 Furthermore, we highlight itaconate and fumarate derivatives as potential therapeutic options in NLRP3- and IL-1alpha-driven diseases, including in the brain. Fumarates NLR family pyrin domain containing 3 Homo sapiens